“Musk's Department of Government Efficiency (DOGE) did not make any cuts to the U.S. President's Emergency Plan for AIDS Relief (PEPFAR).”
Attributed to New York Post (Karol Markowicz) relaying Musk's explanation
The article denies Nicholas Kristof's allegation that Musk cut funding that led to deaths, stating that DOGE did not cut PEPFAR and that lifesaving funding continued and is now administered by the State Department.
What the proof shows
Contemporary government records and reporting show DOGE and the Trump administration took actions that reduced, froze, or sought to rescind U.S. global-health spending (including funds historically implemented through USAID/PEPFAR), even while the State Department and courts later took steps to preserve life‑saving treatment. Multiple reputable sources document: (a) DOGE-linked rescission proposals and execution actions targeted foreign‑assistance accounts and at times listed PEPFAR among items to be clawed back; (b) USAID programs and awards were suspended, many awards were cancelled or transferred to the State Department when USAID was shuttered; and (c) internal State Department data show overall PEPFAR spending fell (reportedly ~30% in FY2025) though the department reported treatment numbers remained stable. Therefore the absolute statement “DOGE did not make any cuts to PEPFAR” is misleading: DOGE-led policy and operational changes disrupted and reduced PEPFAR‑linked funding and implementation, even if U.S. treatment delivery was later preserved in part through waivers, transfers to State, Congressional protection of some appropriations, and court orders.
Corrected version
DOGE and the administration took actions that disrupted and reduced PEPFAR‑linked funding and USAID implementation; some PEPFAR treatment services were later preserved or shifted to the State Department and Congress removed certain proposed rescissions.
Automated evidence confidence: 0%
References and proof
Every link was reachable when published. Each proof point states how that source bears on the claim.
Elon Musk is in the rabid left’s crosshairs — but he’s not the true target ↗
New York PostKarol Markowicz relays Musk's explanation that DOGE did not cut PEPFAR and that lifesaving funding continued and is now administered by the State Department.
First on ABC: Memo to Rubio details data on HIV/AIDS treatment program under Trump administration ↗
ABC NewsAn internal State Department memo (seen by ABC) says overall PEPFAR spending fell by roughly 30% in FY2025, though 20.6 million people were reported as receiving antiretroviral treatment in FY2025—the same number as in 2024.
Overview of President Trump’s Executive Actions on Global Health ↗
Kaiser Family Foundation (KFF)KFF documents that USAID—historically PEPFAR's main implementing agency—was dismantled and many USAID global health activities were transferred to State (GHSD); it also notes an FY2026 budget request proposing large reductions to PEPFAR and references legal steps (waivers, injunctions) taken in early 2025 to protect urgent treatment.
Republicans Scrap Plan to Cut $400 Million From PEPFAR Anti‑AIDS Program ↗
TimeTime reports the rescissions package—an administration initiative associated with DOGE—initially included a $400 million cut to PEPFAR but that item was later removed by Senate negotiators; the article states the rescissions package was tied to DOGE's effort to claw back previously appropriated funds.
After months of cuts, State Department says it's officially shuttering USAID ↗
ABC NewsABC published a March 28, 2025 memo (obtained by the outlet) in which a senior official—formerly of DOGE—told USAID staff that the State Department 'intends to assume responsibility for many of USAID's functions' after months of layoffs and revocations of awards; the piece ties those dismantling actions to DOGE activity.
Elon Musk says Doge didn’t cut HIV programs. But it threw a ‘miracle drug’ into chaos ↗
The GuardianReporting documents that DOGE actions—layoffs, freezes, and seizure of systems at USAID—disrupted PEPFAR operations and created confusion that affected drug distribution and program functioning.
Discussion
Disagreement is welcome. Spam and abuse are not.
No published comments yet. Add evidence or challenge the reasoning.
Members can comment for free
Create a free membership or sign in.